Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity

Alzheimer’s disease (AD) is a devastating neurodegenerative disease with more than 50 million people suffer from it. Unfortunately, none of the currently available drugs is able to improve cognitive impairment in AD patients. Urolithin A (UA) is a metabolite obtained from ellagic acid and ellagitann...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Huang-Ju, Su, Chih-Jou, Peng, Chao-Shiang, Lin, Tony Eight, HuangFu, Wei-Chun, Hsu, Kai-Cheng, Hwang, Tsong-Long, Pan, Shiow-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281726/
https://www.ncbi.nlm.nih.gov/pubmed/37335158
http://dx.doi.org/10.38212/2224-6614.3462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281726/
https://www.ncbi.nlm.nih.gov/pubmed/37335158
http://dx.doi.org/10.38212/2224-6614.3462

Ejemplares similares